Data and information related to Global Fund grants has moved and is now available on the Data Explorer. Please use this site.


Zimbabwe has successfully scaled up interventions to respond to HIV, tuberculosis and malaria. The country recorded a 30 percent increase in the number of people on antiretroviral therapy in 2014 and 2015, and has achieved almost universal diagnosis of malaria cases before treatment. Zimbabwe has had an increase in tuberculosis treatment success from 79 percent in 2014 to 83 percent in 2015. The country continues to invest in strengthening health systems through retention of health care workers, building community health systems and scaling up programs for HIV, TB and malaria. The country’s leadership role in increasing domestic financing through the AIDS levy is regarded as an international best practice.

However, with an estimated HIV prevalence of 14.7 in 2015, the epidemic in Zimbabwe remains one of the biggest in the world. Malaria is a major public health problem and the country is among 30 TB high-burden countries. The incidence of TB in Zimbabwe has increased dramatically in recent years, with TB now being the most common cause of death for people living with HIV.


Country documentation available on the Data Explorer

For documents pertaining to a specific grant, please select a grant from the list.